ES2146049T3 - Benzoilguanidinas, procedimiento para su preparacion y medicamento que las contiene. - Google Patents
Benzoilguanidinas, procedimiento para su preparacion y medicamento que las contiene.Info
- Publication number
- ES2146049T3 ES2146049T3 ES97109546T ES97109546T ES2146049T3 ES 2146049 T3 ES2146049 T3 ES 2146049T3 ES 97109546 T ES97109546 T ES 97109546T ES 97109546 T ES97109546 T ES 97109546T ES 2146049 T3 ES2146049 T3 ES 2146049T3
- Authority
- ES
- Spain
- Prior art keywords
- sup
- substitutes
- indicated
- benzoilguanidines
- procedure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
LAS BENZOYLGUANIDINAS DE LA FORMULA I EN LA CUAL CORRESPONDEN: M 1 O 2; UNO DE LOS SUSTITUYENTES (R2) Y R(3) HIDROGENO; Y CADA UNO DE LOS OTROS SUSTITUYENTES R(2) Y R(3) O Y R(4), R(13), R(14), R(15), R(24), R(31), R(32), G, H, I, Y K, QUE TIENEN LAS CORRESPONDENCIAS INDICADAS EN LAS REIVINDICACIONES, SON VALIOSOS MEDICAMENTOS ANTIARRITMICOS CON COMPONENTES CARDIOPROTECTORES, VALIDOS TAMBIEN PARA LA PREVENCION DE DAÑOS ISQUEMICAMENTE INDUCIDOS, EN ESPECIAL EN EL DESENCADENAMIENTO DE ARRITMIAS CARDIACAS ISQUEMICAMENTE INDUCIDAS. MERCED A LA INHIBICION DEL MECANISMO DE INTERCAMBIO CELULAR NA{SUP,+}/H{SUP,+}, PODRAN EMPLEARSE PARA EL TRATAMIENTO AGUDO O CRONICO DE DAÑOS PRODUCIDOS POR ISQUEMIA. SE CARACTERIZAN ADEMAS POR SU FUERTE EFECTO INHIBIDOR DE LA PROLIFERACION DE CELULAS. ESTAN INDICADOS PARA PREVENIR LA HIPERTENSION SANGUINEA. ADEMAS, REDUCEN LAS CONCENTRACIONES ELEVADAS DE SUERO EN LDL Y VLDL.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19624178A DE19624178A1 (de) | 1996-06-18 | 1996-06-18 | Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2146049T3 true ES2146049T3 (es) | 2000-07-16 |
Family
ID=7797197
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES97109546T Expired - Lifetime ES2146049T3 (es) | 1996-06-18 | 1997-06-12 | Benzoilguanidinas, procedimiento para su preparacion y medicamento que las contiene. |
Country Status (31)
Country | Link |
---|---|
US (1) | US6001881A (es) |
EP (1) | EP0814077B1 (es) |
JP (1) | JP3977897B2 (es) |
KR (1) | KR100498799B1 (es) |
CN (1) | CN1064676C (es) |
AR (1) | AR012536A1 (es) |
AT (1) | ATE191469T1 (es) |
AU (1) | AU711734B2 (es) |
BR (1) | BR9703617A (es) |
CA (1) | CA2207886A1 (es) |
CZ (1) | CZ291848B6 (es) |
DE (2) | DE19624178A1 (es) |
DK (1) | DK0814077T3 (es) |
ES (1) | ES2146049T3 (es) |
GR (1) | GR3033299T3 (es) |
HR (1) | HRP970332B1 (es) |
HU (1) | HUP9701057A3 (es) |
ID (1) | ID17321A (es) |
IL (1) | IL121085A0 (es) |
MX (1) | MX9704486A (es) |
MY (1) | MY117304A (es) |
NO (1) | NO307928B1 (es) |
NZ (1) | NZ328100A (es) |
PL (1) | PL185756B1 (es) |
PT (1) | PT814077E (es) |
RU (1) | RU2193025C2 (es) |
SI (1) | SI0814077T1 (es) |
SK (1) | SK282351B6 (es) |
TR (1) | TR199700508A2 (es) |
TW (1) | TW374759B (es) |
ZA (1) | ZA975312B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19608161A1 (de) * | 1996-03-04 | 1997-09-11 | Hoechst Ag | Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE19713427A1 (de) * | 1997-04-01 | 1998-10-08 | Hoechst Ag | Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE10001879A1 (de) * | 2000-01-19 | 2001-07-19 | Aventis Pharma Gmbh | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
US6641811B1 (en) * | 2000-02-10 | 2003-11-04 | Cornell Research Foundation, Inc. | Use of angiotensin II inhibitors to prevent malignancies associated with immunosuppression |
US7828840B2 (en) * | 2007-11-15 | 2010-11-09 | Med Institute, Inc. | Medical devices and methods for local delivery of angiotensin II type 2 receptor antagonists |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4318756A1 (de) * | 1993-06-05 | 1994-12-08 | Hoechst Ag | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE4328869A1 (de) * | 1993-08-27 | 1995-03-02 | Hoechst Ag | Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE4430213A1 (de) * | 1994-08-28 | 1996-02-29 | Merck Patent Gmbh | Arylbenzoylguanidine |
DE4430916A1 (de) * | 1994-08-31 | 1996-03-07 | Merck Patent Gmbh | Alkyl-benzoylguanidin-Derivate |
DE4430861A1 (de) * | 1994-08-31 | 1996-03-07 | Merck Patent Gmbh | Heterocyclyl-benzoylguanidine |
DE19608162A1 (de) * | 1996-03-04 | 1997-09-11 | Hoechst Ag | Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
-
1996
- 1996-06-18 DE DE19624178A patent/DE19624178A1/de not_active Withdrawn
-
1997
- 1997-06-03 PL PL97320326A patent/PL185756B1/pl not_active IP Right Cessation
- 1997-06-04 US US08/868,750 patent/US6001881A/en not_active Expired - Lifetime
- 1997-06-12 EP EP97109546A patent/EP0814077B1/de not_active Expired - Lifetime
- 1997-06-12 DK DK97109546T patent/DK0814077T3/da active
- 1997-06-12 PT PT97109546T patent/PT814077E/pt unknown
- 1997-06-12 ES ES97109546T patent/ES2146049T3/es not_active Expired - Lifetime
- 1997-06-12 AT AT97109546T patent/ATE191469T1/de not_active IP Right Cessation
- 1997-06-12 DE DE59701388T patent/DE59701388D1/de not_active Expired - Lifetime
- 1997-06-12 SI SI9730060T patent/SI0814077T1/xx unknown
- 1997-06-13 AR ARP970102605A patent/AR012536A1/es unknown
- 1997-06-16 TR TR97/00508A patent/TR199700508A2/xx unknown
- 1997-06-16 MY MYPI97002694A patent/MY117304A/en unknown
- 1997-06-16 SK SK766-97A patent/SK282351B6/sk unknown
- 1997-06-16 AU AU24942/97A patent/AU711734B2/en not_active Ceased
- 1997-06-16 TW TW086108285A patent/TW374759B/zh active
- 1997-06-16 ID IDP972057A patent/ID17321A/id unknown
- 1997-06-16 IL IL12108597A patent/IL121085A0/xx not_active IP Right Cessation
- 1997-06-16 CN CN97113806A patent/CN1064676C/zh not_active Expired - Fee Related
- 1997-06-16 NZ NZ328100A patent/NZ328100A/en unknown
- 1997-06-17 CA CA002207886A patent/CA2207886A1/en not_active Abandoned
- 1997-06-17 HU HU9701057A patent/HUP9701057A3/hu unknown
- 1997-06-17 CZ CZ19971887A patent/CZ291848B6/cs not_active IP Right Cessation
- 1997-06-17 HR HR19624178.2 patent/HRP970332B1/xx not_active IP Right Cessation
- 1997-06-17 ZA ZA9705312A patent/ZA975312B/xx unknown
- 1997-06-17 NO NO972793A patent/NO307928B1/no unknown
- 1997-06-17 JP JP15938297A patent/JP3977897B2/ja not_active Expired - Fee Related
- 1997-06-17 MX MX9704486A patent/MX9704486A/es not_active IP Right Cessation
- 1997-06-17 RU RU97109528/04A patent/RU2193025C2/ru not_active IP Right Cessation
- 1997-06-18 BR BR9703617A patent/BR9703617A/pt not_active Application Discontinuation
- 1997-06-18 KR KR1019970025282A patent/KR100498799B1/ko not_active IP Right Cessation
-
2000
- 2000-04-21 GR GR20000400981T patent/GR3033299T3/el not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2150496T3 (es) | Cicloalquilimidazopiridinas condensadas. | |
ECSP941135A (es) | Antagonistas triciclicos de vasopresina de benzacepina | |
ES2074490T3 (es) | Procedimiento para la elaboracion de un preparado de inmunoglobulina g tolerable por via intravenosa. | |
BR9712765A (pt) | Processos e composições para estimulação do crescimento de neurites utilizando compostos com afinidade para fkbp12 em combinação com fatores neurotróficos | |
BR9406080A (pt) | Compostos que tem tanto antividade de anaonista potente de calcio como de antioxidante e uso dos mesmos como agentes citoprotetores | |
ECSP074704A (es) | Combinaciones de inhibidor(es) de la absorción de esterol con modificador(es) sanguíneos para tratar cuadros vasculares | |
ES2176600T3 (es) | Derivado de la propiofenona y procedimientos para su preparacion. | |
ES2062355T3 (es) | Composicion farmaceutica que comprende loratadina, ibuprofeno y pseudoefedrina. | |
BR0008447A (pt) | Métodos de tratamento de distúrbios mitocondriais | |
ES2012809B3 (es) | Derivados del taxol, su preparacion y composiciones farmaceuticas que los contienen. | |
ES2168395T3 (es) | Nueva formulacion antitrombotica, procedimiento para su preparacion y utilizacion de la misma. | |
AR004253A1 (es) | Sulfonimidoamidas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico asi como medicamento quelas contiene. | |
BR9811923A (pt) | Compostos possuindo atividade neuronal | |
BR0015939A (pt) | Sistemas terapêuticos transdérmicos com estabilidade aperfeiçoada e um processo para a sua preparação | |
BR9910329A (pt) | Composto, composição farmacêutica, processo para estimular a liberação do hormÈnio de crescimento da pituitária de um mamìfero, e, uso de um composto | |
ES2146049T3 (es) | Benzoilguanidinas, procedimiento para su preparacion y medicamento que las contiene. | |
CO5050328A1 (es) | Sistema solvente para la mejor penetracion de compuestos farmaceuticos | |
ES2043725T3 (es) | Aminofenil-carbamatos substituidos. | |
ES2154002T3 (es) | 2-naftoilguanidinas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene. | |
US3574857A (en) | Antilipidemic methods using glutamic acid,threonine and proline | |
MX9203405A (es) | Compuestos activos para usarse en el tratamiento de tumores. | |
ES2054790T3 (es) | Compuestos que tienen actividad cardiovascular. | |
ES2147796T3 (es) | Composicion para el tratamiento o la prevencion del herpes. | |
BR0214487A (pt) | Composição farmacêutica que compreende uma combinação de metformina e um ácido 4-oxobutanóico, e o uso da mesma para o tratamento de diabetes | |
MX9303248A (es) | Compuestos de fosfanato novedosos que contienen nitrogeno cuaternario, composiciones farmaceuticas, y metodos para tratar metabolismo anormal de calcio y fosfato. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 814077 Country of ref document: ES |